PLXP VS GCTK Stock Comparison
Performance
PLXP10/100
10/100
PLXP returned -96.94% in the last 12 months. Based on the other stocks in its sector with an average return of -31.58%, its performance is below average giving it a grade of 10 of 100.
GCTK10/100
10/100
GCTK returned -91.40% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Forecast
PLXP75/100
75/100
1 analysts offer 12-month price forecasts for PLXP. Together, they have an average target of 0, the most optimistic forecast put PLXP at 0 within 12-months and the most pessimistic has PLXP at 0.
GCTK
"Forecast" not found for GCTK
Sentiment
PLXP71/100
71/100
PLXP had a bullish sentiment score of 70.81% across Twitter and StockTwits over the last 12 months. It had an average of 9.26 posts, 0.97 comments, and 3.56 likes per day.
GCTK
"Sentiment" not found for GCTK
Technicals
PLXP10/100
10/100
PLXP receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
GCTK10/100
10/100
GCTK receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
Earnings
PLXP10/100
10/100
PLXP has missed earnings 9 times in the last 20 quarters.
GCTK
"Earnings" not found for GCTK
Profit
PLXP41/100
41/100
Out of the last 20 quarters, PLXP has had 8 profitable quarters and has increased their profits year over year on 6 of them.
GCTK10/100
10/100
Out of the last 20 quarters, GCTK has had 1 profitable quarters and has increased their profits year over year on 1 of them.
Volatility
PLXP30/100
30/100
PLXP has had a lower than average amount of volatility over the last 12 months giving it a grade of 29 of 100.
GCTK67/100
67/100
GCTK has had a higher than average amount of volatility over the last 12 months giving it a score of 66 of 100.
All score calculations are broken down here to help you make more informed investing decisions
PLx Pharma Inc. Common Stock Summary
Nasdaq / PLXP
Healthcare
Drug Manufacturers—Specialty & Generic
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
GlucoTrack, Inc. Common Stock Summary
Nasdaq / GCTK
Healthcare
Medical - Instruments & Supplies
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare PLXP to other companies in the same or a similar industry.
